In the coming years, the cancer gene therapy market size is projected to witness considerable growth, particularly due to the surging prevalence of cancer, increasing investments in research & development (R&D) activities, improved regulatory framework, acceptance of gene therapy for the treatment of the disease, rising popularity of deoxyribo nucleic acid vaccines, and technological advancements. Clinical research laboratories, hospitals, biotechnology companies, and oncology institutes are the major end-users in the cancer gene therapy industry.
Download sample copy of this report: www.psmarketresearch.com/market-analysis/cancer-gene-therapy-market/report-sample
The different therapies utilized for treatment are oncolytic virotherapy, gene transfer, and immunotherapy. Out of these, the gene transfer therapy is expected to lead the global cancer gene therapy market in the near future. There are several ways to apply gene therapy, for example, replacing absent or abnormal genes with healthy ones, changing the way genes are regulated, and introducing foreign genes in cells, which alter their function or/and survival. The gene transfer therapy further has several types, namely electroporation, magnetofection, naked/plasmid vectors, sonoportation, and gene gun.
Asia-Pacific (APAC) is projected to register the fastest growth in demand for cancer gene therapy in the coming years. The growth of the cancer gene therapy market in the region is ascribed to the improving healthcare infrastructure and increasing government initiatives. The healthcare infrastructure in the region is improving due to the rising disposable income of people in emerging economies, which, in turn, is resulting in the growing affordability of innovative treatment options. Moreover, countries including Korea and India have a large patient pool, which is further contributing to the growth of the industry.
Pre-Purchase Inquiry at: www.psmarketresearch.com/send-enquiry?enquiry-url=cancer-gene-therapy-market
Cancer Gene Therapy Market Segmentation
- Gene induced immunotherapy
- Delivery of cytokines gene
- Delivery of tumor antigen gene
- Oncolytic Virotherapy
- Retro virus
- Adeno associated virus
- Herpes simplex virus
- Alpha virus
- Vaccinia virus
- Simian virus
- Gene Transfer
- Naked/plasmid vectors
- Gene gun
- Oncology institutes
- Biotechnological companies
- Clinical research laboratories